Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Net Change in Cash : ¥-64 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Luoxin Pharmaceuticals Group Stock Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Luoxin Pharmaceuticals Group Stock Co's Net Change in Cash for the three months ended in Mar. 2024 was ¥-1 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-64 Mil.

Luoxin Pharmaceuticals Group Stock Co Net Change in Cash Historical Data

The historical data trend for Luoxin Pharmaceuticals Group Stock Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luoxin Pharmaceuticals Group Stock Co Net Change in Cash Chart

Luoxin Pharmaceuticals Group Stock Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-10.41

186.92

480.61

-659.23

-254.41

Luoxin Pharmaceuticals Group Stock Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-191.36	295.90	-204.50	-154.46	-1.42

Luoxin Pharmaceuticals Group Stock Co Net Change in Cash Calculation

Luoxin Pharmaceuticals Group Stock Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	466.888	+	957.426	+	-1680.908	+	2.18
	=	-254

Luoxin Pharmaceuticals Group Stock Co's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -96.08 + 9.198 + 84.032 + 1.433

= -1

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Luoxin Pharmaceuticals Group Stock Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Luoxin Pharmaceuticals Group Stock Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) » Definitions » Net Change in Cash

Comparable Companies

SHSE:605199 SHSE:688553 SHSE:600789 SHSE:603367 SZSE:002437 SZSE:301089 SZSE:000566 SZSE:300683 SHSE:688073 SZSE:301211 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

N/A

Address

85 Faraday Road, Floor 1-3, Building 1, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.luoxin.cn

Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.

Executives

Ye Bang Mi Supervisors

Fang Xiu Bao Directors, executives

Zhu Fu Lin Directors, executives

Chen Li Supervisors

Yao Liang Directors, executives

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Headlines

No Headlines

Ye Bang Mi	Supervisors
Fang Xiu Bao	Directors, executives
Zhu Fu Lin	Directors, executives
Chen Li	Supervisors
Yao Liang	Directors, executives